NEWS
Latest Articles and Papers
03/24/2021
Trispecific CD19-CD20-CD22-targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models
Featuring: Dimiter Dimitrov, PhD, ScD
01/26/2021
Developability Assessment of an Isolated CH2 Immunoglobulin Domain
Featuring: Dimiter Dimitrov, PhD, ScD
11/02/2020
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection
10/15/2020
High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models
10/12/2020
Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies
Featuring: Dimiter Dimitrov, PhD, ScD
10/12/2020
One small part of a human antibody has the potential to work as a drug for both prevention and therapy of COVID-19
09/15/2020
Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma
Featuring: Dimiter Dimitrov, PhD, ScD
09/09/2020
Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade
Featuring: Dimiter Dimitrov, PhD, ScD
08/07/2019
Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model
Featuring: Dimiter Dimitrov, PhD, ScD
